Clínica Etermal

17/10/2025

La pregunta sobre el origen de la reacción al gluten ha intrigado a la ciencia por décadas. Aunque sabíamos que el intestino era el órgano más afectado,

12/10/2025

12/10/2025

Agua con gas: por qué es una alternativa más digestiva y saludable que la normal

11/10/2025

Dieta cetogénica baja en grasas

26/09/2025

La Ataxia por gluten es la manifestación neurológica asociada a la Celiaquía más descrita en la bibliografía médica.

Hoy es su día internacional y aquí os contamos en qué consiste. 👇

https://celicidad.net/ataxia-por-gluten/

21/09/2025

https://www.facebook.com/share/p/1JbF1xcFeA/?mibextid=wwXIfr

🔇 El 🔵 en el suplemento de de 📰

✍🏻 “El poder del agua termal para reforzar la salud: el balneario se convierte en otoño e invierno en un refugio de salud y prevención, ya conocido por los romanos”.

👇 Descúbrelo aquí:
https://lne.es/sociedad/2025/09/19/agua-termal-reforzar-salud-121738191.html

🔵

07/09/2025

Stessa gamba, poche settimane di distanza: oggi vi mostriamo lo straordinario risultato di una paziente dopo un ciclo di cure termali (balneoterapia + cura idropinica) per la .

💧 Alle curare le patologie cutanee in modo 100% naturale è possibile, grazie alle proprietà lenitive, antinfiammatorie e rigeneranti della nostra Acqua Termale.

La terapia termale richiede tempo, è vero, e può essere un processo lungo: ma è una cura scientificamente validata e naturale, che ogni anno aiuta migliaia di pazienti a stare meglio nella propria pelle.

🙏 Ringraziamo la persona che ci ha inviato queste fotografie, rispettando il suo desiderio di rimanere anonima.

Se anche tu sei un paziente delle Terme di Comano e desideri mostrarci il tuo “prima e dopo”, scrivici in privato o inviaci una mail a 📧 marketing@termecomano.it.

07/09/2025

A groundbreaking therapy, based on inhibiting the USAG‑1 protein, is now undergoing human clinical trials in Japan to test whether it can regenerate missing teeth—potentially even a third set—by reactivating dormant tooth buds. This is real, ongoing research.

What's happening now:

Human trials began around September or October 2024. These studies involve 30 healthy adult males (ages 30–64), each missing at least one tooth, and aim to assess the safety and dosing of the drug when administered intravenously.

The drug works by blocking USAG‑1, a protein that suppresses tooth development; preclinical successes include regrowing teeth in mice and ferrets.

If adult trials prove safe and effective, the plan is to expand testing to children (ages 2–6 or 2–7) with congenital tooth agenesis.

Experts project public availability by around 2030, contingent on trial success and regulatory approval.

Broader context:

This therapy could potentially offer an alternative to dentures and implants, especially for those with congenital tooth loss or injury-related tooth loss.

Meanwhile, other global efforts in tooth regeneration are also underway—such as lab-grown teeth using scaffolds (Tufts University), enamel-forming proteins (University of Washington), and fully integrated lab-grown teeth (King’s College London)—suggesting a broader push toward regenerative dentistry.

According to Wikipedia, the first clinical trial for tooth regeneration in Japan started around 2023 using a medicine aimed at stimulating tooth regrowth via USAG‑1 inhibition.